Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG).

Autor: Akyildiz A; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. drakyildizarif@gmail.com., Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Koksal B; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Karaoglan BB; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kivrak D; Department of Medical Oncology, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey., Ismayilov R; Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey., Aslan F; Department of Medical Oncology, Ankara Medical Park Hospital, Ankara, Turkey., Sutcuoglu O; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey., Yazici O; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey., Kadioglu A; Department of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Alan O; Department of Medical Oncology, Koç University, Istanbul, Turkey., Majidova N; Department of Medical Oncology, Marmara University, Pendik Training and Research Hospital, Istanbul, Turkey., Erciyestepe M; Department of Medical Oncology, Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey., Ozcan E; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey., Akdag G; Department of Medical Oncology, University of Health Science, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey., Taban H; Department of Medical Oncology, Samsun Training and Research Hospital, Samsun, Turkey., Kaya AO; Department of Medical Oncology, Biruni University Faculty of Medicine, Istanbul, Turkey., Guliyev M; Department of Medical Oncology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey., Yildirim N; Department of Medical Oncology, Firat University Faculty of Medicine, Elazig, Turkey., Sakalar T; Department of Medical Oncology, Necip Fazil City Hospital, Kahramanmaras, Turkey., Yazilitas D; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey., Unal C; Department of Medical Oncology, Gayrettepe Florence Nightingale Hospital, Istanbul, Turkey., On S; Department of Oncology, Ege University Faculty of Medicine, Izmir, Turkey., Biter S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Demirci NS; Department of Medical Oncology, Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey., Senler FC; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey., Kemal Y; Department of Medical Oncology, Altinbas University Faculty of Medicine, Samsun, Turkey., Halil OD; Department of Medical Oncology, Near East University Hospital, Nicosia, Cyprus., Gullu I; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Sep; Vol. 281 (9), pp. 4991-4999. Date of Electronic Publication: 2024 May 25.